Evidence map›Paper›PMID 29276655›Full record

ArticleCurrent ophthalmology reports2017

Polypoidal Choroidal Vasculopathy.

Joon-Bom Kim, Rajinder S Nirwan, Ajay E Kuriyan

Abstract read
In one paragraph

Article in Current ophthalmology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. [Stressed country doctor with acute visual loss : Clear diagnosis?]Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2018
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joon-Bom KimFlaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA.
Rajinder S NirwanFlaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA.
Ajay E KuriyanFlaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · US

Funding

VISUAL SCIENCE RESEARCH CTR SUPPORTP30EY001319 · NEI · UNIVERSITY OF ROCHESTER · PI MICHELE RUCCI · 1985 to 2026
$17.5M
A novel in vitro model of thyroid ophthalmopathyR03EY014564 · NEI · UNIVERSITY OF ROCHESTER · PI FELDON, STEVEN E · 2003 to 2005
$473k
NEI NIH HHS P30 EY001319NEI NIH HHS R03 EY014564
6 · The paper itself

Abstract

purpose of reviewThe goal of this paper is to review the recent literature of polypoidal choroidal vasculopathy (PCV) and provide an update on the epidemiology, pathophysiology, clinical findings, and management. RECENT

findingsAlthough indocyanine-green angiography (ICGA) is still the gold standard for diagnosis of PCV, the use of SUMMARY: PCV is a disease most commonly in Asians and African-Americans and presents with an orange-red nodule in the macula or the peripapillary region. While ICGA remains the most accurate method to diagnose PCV, newer non-invasive imaging modalities (eg. OCT-A and

Indexed as

age-related macular degenerationchoroidal neovascularizationophthalmologypolypoidal choroidal vasculopathy

Identifiers

PMID29276655
PMCPMC5736141
OpenAlexW2607474452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.